Risk stratification model for the pharmaceutical care of oncology patients with solid or hematologic neoplasms

CONCLUSION: This stratification model enables the identification of cancer patients requiring a higher level of pharmaceutical care and facilitates the adjustment of care capacity. Validation of the model in a representative population is necessary to establish its effectiveness.PMID:38461113 | DOI:10.1016/j.farma.2023.12.001

Source: Farmacia Hospitalaria - March 9, 2024 Category: Drugs & Pharmacology Authors: Beatriz Bernardez Irene Mangues Bafalluy Virginia Mart ínez Callejo Juan Jos é Fernández Ávila Jose Antonio Marcos Rodr íguez Maria Angeles Parada Aradilla Mar ía José Martínez Bautista Source Type: research